BioSpace News Archive

The American Council for Patient Liberty created a website and produced an educational video to inform Arizonans and elected officials about voter protected medical marijuana as well as hemp extracts in Arizona.

Wellness-Focused Hotel Features Table 55 Farm-to-Table Restaurant and Rooms for Extended Stays

Rainier Therapeutics, Inc., a privately-held clinical stage drug development company, today announced the presentation of preliminary data from its Phase 2 trial of vofatamab, a fibroblast-growth-factor-receptor 3 (FGFR3) targeted antibody, at the 2019 ASCO Genitourinary Cancers Symposium in San Francisco.

HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of Michael A. Kelly to the Company’s Board of Directors.

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release its fourth quarter and year-end financial results on Friday, February 22, 2019.

Helix TCS, Inc. (OTCQB: HLIX), based in Denver, Colorado focused on critical infrastructure services to the legal cannabis industry, today announced that Zachary L. Venegas, Executive Chairman and CEO, will present live at VirtualInvestorConferences.com on February 20th.

According to Coherent Market Insights, the global nanopharmaceuticals market was valued at US$ 28,434.3 million in 2017, and is projected to exhibit a CAGR of 22.1% over the forecast period (2018 – 2026).

From 1999 to 2016, the rate of suicides in the U.S. increased by 30 percent. It’s now the second-leading cause of death for 10 to 34-year-olds. Social media bullying, increasing economic disparity, returning veterans traumatized by war, and unintended consequences of the opioid crisis have all been cited as reasons for the rise in America.

Fresenius Kabi today announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the Fenwal Amicus® Red Blood Cell Exchange (RBCx) system.

Triple Ring Technologies, a leading research and development firm that partners with its clients to develop innovative products and to launch new businesses, announces today that their Vice President of Projects, Christina Sejr Pedersen, recently won the coveted Hamdan Bin Mohammed Award for the most Innovative Idea in Project Management